EHA:Pegcetacoplan mantiene una respuesta duradera en pacientes con hemoglobinuria paroxismal nocturna

By In The News
June 12, 2021 in The Headlines

Recommended Posts

In The News

Posted June 12, 2021

- Share

Posted June 12, 2021

- European Hematology Association - Pegcetacoplan mantiene una respuesta duradera en pacientes con hemoglobinuria paroxismal nocturna durante 48 semanas LA HAYA, Países Bajos, 12 de junio de 2021 /PRNewswire/ -- El estudio PEGASUS de fase 3 demostró previamente que pegcetacoplan, un...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  221806
2. Jaydee
  17647
3. deicer
  13207
4. Kip Powick
  12292
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.2k
- Total Posts
  
  564.3k

Sign In

EHA:Pegcetacoplan mantiene una respuesta duradera en pacientes con hemoglobinuria paroxismal nocturna

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support